top of page




  • Won National Defense Innovation Award at the Defense Techconnect Conference 2022. 

  • Won National Innovation Award at the Tech Connect World Conference in the year 2017 and 2018.

  • Won a dozen National Innovation Showcase over the past decade in the Tech Connect World Conference. 

  • Won the Defense Techconnect showcase 2019.

  • Won the finalist in the DOD National Security Challenge Competition in Energy Storage in 2010.

  • Federal and local government’s innovative grants awards from 2011 to 2021.



  • DOD Raytheon Mentor-Protégé program with Mentor Mr. Kevin Bowen from 2010-2013

  • The Techconnect World Conference press released it's on the spotlight news of ABS’s nanobiomimetic Mem-capacitor innovation with applications in medical and energy storage in 2012.

  • ABS received Montgomery county’s consecutive 2 years acknowledgment letters for mentoring minority Montgomery college students (2011-2012). 

  • Dr. E. Chen, the CEO of ABS, was in the honorary lists at the Montgomery county’s Woman Entrepreneur conference in 2012. 

  • Dr.  E. Chen, the CEO of ABS, was on the lists of Marquis’s Who’s Who 2018 Albert Nelson Marquis Lifetime Achievement Award 

  • The Washington Post reported ABS’s innovative technology in the new energy storage device of fuel cell, on May 24, 2012.

  • ABS’s CEO Dr. E. Chen gave business pitches on the DOD’s on the SpotLight Challenge Innovation in Energy at the Techconenct World conference in 2012 and 2018. 

  • Dr. E. Chen gave business pitches on the SpotLight Challenge Innovation in Medical at the Techconenct World conference in 2012 and 2017.

  • ABS was honored as the top National Innovator in the title of Room-temperature Flexible Josephson Junction Superconductive Energy Storage System by the Techconnect World conference Review Committee at, June, 19-21, 2022.

  • ABS was honored as the top National Innovator in the title of NanoBiomimetic Reagent-free Quantum Sensing by the Techconnect World conference Review Committee at, June, 19-21, 2022.

AWARD-WINNING Medical Devices, Innovation & Technology 


Among the more than a dozen issued patents and a dozen pending patents by the US Patents and Trade Mark Office (USPTO), the significances of the inventions in the medical devices’ diagnostic and monitoring are:

  • The nanopore structured biomimetic electrochemical sensor (US 8,083,926). This patent became the most cited nano-biomimetic sensor patent according to

  • Dr. E. Chen’s invented patent had enlisted by on March 8, 2010, as the ranking #12 of the Top 100 Inventors in the World. 

  • Our issued patent portfolio shows the nano-biomimetic electrochemical device has a biosensing and energy storage dual function and is capable of reliably detecting a single cancer cell in biological specimens (US 8,083,926, US 8,641,876, US 9,534,999). 

  • Our issued patent portfolio shows mem-transformer, memristors, and memcapacitors comprised of the crosslinked organic polymer formed nanostructure biomimetic membranes that have dual biosensing functions to directly detect the biomarker beta-amyloid that affects the reentry energy change in aj/bit/nM. The device detects 3D dynamic neuronal circuitry change from an asymptomatic stage I to a late-stage IV. The Pathological High-Frequency Oscillation (PHFO) in a spatiotemporal contour map detected is clinically beneficial. The PHFO distributions in an energy-sensory image are helpful to medical doctors. (US10,684,244, US 10,441,169).  

  • Our issued patent portfolio shows the first room-temperature Josephson toroidal vertex quantum superconductive/memristive devices detected collagen protein in a quantum manner at zero-bias potential, that avoided protein -interference. Furthermore, quantized conductivity values are proportional to the protein’s concentrations was demonstrated. (US 11,079,354).

  • Our issued patent portfolio shows toroidal array devices comprised of cross-linked organic polymers formed nanostructured biomimetic membrane direct and reagent-free detects the presence of endotoxin LPS in a single E. Coli and detects Acetyl CoA with a DOL 37 fM. (US 11,041,843).

  • The US Patent and Trademark Office (USPTO) issued a new patent US 11/708,595 in the title of Nanostructured Biomimetic Protein Superconductive Devices of Making and Its Multiple Applications Thereto on July 25, 2023.  


  • Dr. Chen was invited by the American Chemical Society (ACS) to give an oral presentation of the Nanobiomimetic Reagent-free Sensing of the Triple-negative Breast Cancer in the ACS annual conference on August 19-23, Philadelphia, 2012

  • Montgomery College Spectrum Lecture Series to Feature Dr. E. Chen’s presentation in the title of Development of Biomimetic Diagnostic Services on February 15, 2012

  • Received invitation from the Chairman of the National Small Business Round Table organization to attend the “National Small Business CEO Round Table Annual Conference2013, and 2014.

bottom of page